Experiments for taxon Cynanchum wilfordii (ASCLEPIADACEAE)

150 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
1089262	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
654129	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE C-1-N
221658	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	CYNANDIONE A
707579	PHARMACOLOGY OF EXTRACT - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)
654874	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININE
416129	PHARMACOLOGY OF EXTRACT - IN VITRO	SMOOTH MUSCLE RELAXANT ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
373735	PHARMACOLOGY OF EXTRACT - IN VIVO	TOXIC EFFECT(GENERAL)	Cynanchum wilfordii (ASCLEPIADACEAE)
650733	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	CYNANCHONE A
1141267	ISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	GLAUCOBIOSIDE,BETA: METHYL:GLAUCOBIOSIDE,ALPHA: METHYL:
1070380	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	BARBITURATE POTENTIATION	Cynanchum wilfordii (ASCLEPIADACEAE)
738498	PHARMACOLOGY OF EXTRACT - IN VITRO	ANGIOGENESIS INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)
74579	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE D-1-N
10828	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIINFLAMMATORY ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
654118	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
1120084	PHYTOCHEMICAL SCREENING FORVOUCHER SPECIMEN REPORTED FOR		Cynanchum wilfordii (ASCLEPIADACEAE)	O
792659	PHYTOCHEMICAL SCREENING FOR		Cynanchum wilfordii (ASCLEPIADACEAE)	O
221655	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	ACETOPHENONE,4'-HYDROXY:
726886	VOUCHER SPECIMEN REPORTED FOR		Cynanchum wilfordii (ASCLEPIADACEAE)
369994	PHARMACOLOGY OF EXTRACT - IN VITRO	ORNITHINE DECARBOXYLASE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)
672514	PHARMACOLOGY OF COMPOUND - IN VITRO	SUPEROXIDE DISMUTASE STIMULATION	Cynanchum wilfordii (ASCLEPIADACEAE)	CYNANDIONE
654123	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
654112	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
831209	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE C-1-N
371965	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPOXYGENASE,5: INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININE
606781	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
779728	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Cynanchum wilfordii (ASCLEPIADACEAE)
831210	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE C-2-N
10827	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIINFLAMMATORY ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
549052	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
654128	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE K-1-N
831213	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE C-2-G
654127	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE K-1-N
654134	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	CYNAURICUOSIDE A
740940	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
74583	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE F-1-N
654116	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
1158937	PHARMACOLOGY OF EXTRACT - IN VIVO	BARBITURATE POTENTIATION	Cynanchum wilfordii (ASCLEPIADACEAE)
850281	PHYTOCHEMICAL SCREENING FOR		Cynanchum wilfordii (ASCLEPIADACEAE)	OOOO
654875	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHINE OXIDASE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININE
1101701	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
654872	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININE
1089263	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
221654	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	ACETOPHENONE,2'-5'-DIHYDROXY:
672516	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUTATHIONE PEROXIDASE STIMULATION	Cynanchum wilfordii (ASCLEPIADACEAE)	CYNANDIONE
373738	PHARMACOLOGY OF EXTRACT - IN VIVO	ULCEROGENIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
654119	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
346570	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININE
733716	VOUCHER SPECIMEN REPORTED FOR		Cynanchum wilfordii (ASCLEPIADACEAE)
779729	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Cynanchum wilfordii (ASCLEPIADACEAE)
639240	PHARMACOLOGY OF EXTRACT - IN VITRO	TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)
850697	ISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE C-2-NWILFOSIDE C-2-GWILFOSIDE C-1-GWILFOSIDE C-1-NWILFOSIDE C-3-GWILFOSIDE C-3-N
654111	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
650732	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	CYNANDIONE A
10829	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIINFLAMMATORY ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
654122	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
371964	ISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININE
672519	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTINEUROTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)	CYNANDIONE
831208	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE C-3-N
672513	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTINEUROTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)	CYNANDIONE
654115	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
74580	MEDICINAL FOLKLORE REPORTED FOR	APPETITE STIMULANT	Cynanchum wilfordii (ASCLEPIADACEAE)
654126	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE K-1-N
328143	YIELD IS MORE THAN 100 MGMISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENT		Cynanchum wilfordii (ASCLEPIADACEAE)	PENUPOGENINKIDJORANINCAUDATIN
606780	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
1134772	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF NEW COMPOUND FOLLOWING ACID HYDROLYSIS		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFORIBIOSE
672517	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTINEUROTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)	CYNANDIONE
654133	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	CYNAURICUOSIDE A
369995	PHARMACOLOGY OF EXTRACT - IN VITRO	ORNITHINE DECARBOXYLASE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)
740941	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
1171358	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHEPATOTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
74586	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE G-1-G
866578	X-RAY CHRYSTALLOGRAPHIC STUDIESSTRUCTURE DETERMINATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDCORRECTION OF STRUCTURE		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFORIBIOSE
726887	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIADHESION EFFECT	Cynanchum wilfordii (ASCLEPIADACEAE)
74584	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE W-1-N
672515	PHARMACOLOGY OF COMPOUND - IN VITRO	CATALASE STIMULATION	Cynanchum wilfordii (ASCLEPIADACEAE)	CYNANDIONE
373737	PHARMACOLOGY OF EXTRACT - IN VIVO	HEPATOTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
221653	MEDICINAL FOLKLORE REPORTED FOR	APPETITE STIMULANT	Cynanchum wilfordii (ASCLEPIADACEAE)
755190	ISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	CYNANDIONE A
831211	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE C-3-G
416130	PHARMACOLOGY OF EXTRACT - IN VITRO	SMOOTH MUSCLE STIMULANT ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
654130	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE C-1-N
726888	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
1101703	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
639241	PHARMACOLOGY OF EXTRACT - IN VITRO	TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)
74581	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE K-1-N
1148112	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFORIBIOSE
654109	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
17260	ISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENT		Cynanchum wilfordii (ASCLEPIADACEAE)	LINEOLONEMETAPLEXIGENIN,DEACYL:CINNAMIC ACIDCYMARONIC ACIDSITOSTEROL,BETA:SARCOSTIN
416128	PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY	UTERINE RELAXATION EFFECT	Cynanchum wilfordii (ASCLEPIADACEAE)
369996	PHARMACOLOGY OF EXTRACT - IN VITRO	ORNITHINE DECARBOXYLASE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)
672512	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTINEUROTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
1089260	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
654132	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE C-1-N
654114	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
779726	VOUCHER SPECIMEN REPORTED FOR		Cynanchum wilfordii (ASCLEPIADACEAE)
1089259	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	TOXICITY ASSESSMENT(QUANTITATIVE)	Cynanchum wilfordii (ASCLEPIADACEAE)
654125	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE K-1-N
654136	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	CYNAURICUOSIDE A
1089264	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
865407	HPLC DATA REPORTEDISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENT		Cynanchum wilfordii (ASCLEPIADACEAE)	CYMAROSE,D:CYMAROSE,L:
346568	MEDICINAL FOLKLORE REPORTED FOR	ANTIAGING ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
74585	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE W-3-N
654110	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
776836	VOUCHER SPECIMEN REPORTED FOR		Cynanchum wilfordii (ASCLEPIADACEAE)
750337	PLANT TISSUE CULTURE MARKER CODEVOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININE
221657	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	ACETOPHENONE,4'-HYDROXY-3'-METHOXY:
346567	MEDICINAL FOLKLORE REPORTED FOR	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
639239	VOUCHER SPECIMEN REPORTED FOR		Cynanchum wilfordii (ASCLEPIADACEAE)
755191	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIHEPATOTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)	CYNANDIONE A
1101702	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIMITOTIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
733717	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
654121	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
672518	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTINEUROTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)	CYNANDIONE
707578	PHARMACOLOGY OF EXTRACT - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)
373736	PHARMACOLOGY OF EXTRACT - IN VIVO	TOXIC EFFECT(GENERAL)	Cynanchum wilfordii (ASCLEPIADACEAE)
221652	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cynanchum wilfordii (ASCLEPIADACEAE)	BENZOQUINONE,1-4: 2-ACETYL-3-6-DIAMINO:
831212	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE C-1-G
522245	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIHEPATOTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
74582	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE M-1-N
1141266	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cynanchum wilfordii (ASCLEPIADACEAE)	WILFORIBIOSE
654120	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
654117	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
1089261	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
654131	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	WILFOSIDE C-1-N
1101704	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIMITOTIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
1070381	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	BARBITURATE SLEEPING TIME DECREASED	Cynanchum wilfordii (ASCLEPIADACEAE)
369993	VOUCHER SPECIMEN REPORTED FOR		Cynanchum wilfordii (ASCLEPIADACEAE)
672511	ISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	CYNANDIONE
803321	PLANT TISSUE CULTURE MARKER CODEVOUCHER SPECIMEN REPORTED FORBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININE
776837	PHARMACOLOGY OF EXTRACT - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)
1244954	CRUDE DRUG DESCRIPTIONMICROSCOPY OFMEDICINAL FOLKLORE REPORTED FOR	APPETITE STIMULANT	Cynanchum wilfordii (ASCLEPIADACEAE)
373734	PHARMACOLOGY OF EXTRACT - IN VIVO	TOXIC EFFECT(GENERAL)	Cynanchum wilfordii (ASCLEPIADACEAE)
328144	PMR SPECTRUM REPORTEDCHEMICAL CONVERSION OFMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cynanchum wilfordii (ASCLEPIADACEAE)	SARCOSTIN,12-O-CINNAMOYL-20-O-TIGLOYL:SARCOSTIN,12-O-CINNAMOYL-20-O-IKEMAOYL:
738497	VOUCHER SPECIMEN REPORTED FOR		Cynanchum wilfordii (ASCLEPIADACEAE)
654135	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	CYNAURICUOSIDE A
1089265	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	SPONTANEOUS ACTIVITY REDUCTION	Cynanchum wilfordii (ASCLEPIADACEAE)
346566	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININE
346569	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDEHYDE OXIDASE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININE
458034	PHARMACOLOGY OF EXTRACT - IN VITRO	ALDOSE REDUCTASE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)
416127	PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY	UTERINE STIMULANT EFFECT	Cynanchum wilfordii (ASCLEPIADACEAE)
779727	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Cynanchum wilfordii (ASCLEPIADACEAE)
639242	PHARMACOLOGY OF EXTRACT - IN VITRO	TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)
654873	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDEHYDE OXIDASE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININE
654113	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
606782	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
221656	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cynanchum wilfordii (ASCLEPIADACEAE)	ACETOPHENONE,2'-4'-DIHYDROXY:
1158938	PHARMACOLOGY OF EXTRACT - IN VIVO	BARBITURATE SLEEPING TIME DECREASED	Cynanchum wilfordii (ASCLEPIADACEAE)
733718	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Cynanchum wilfordii (ASCLEPIADACEAE)
416131	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Cynanchum wilfordii (ASCLEPIADACEAE)
654124	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Cynanchum wilfordii (ASCLEPIADACEAE)	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE

Experiments for taxon Cynanchum wilfordii (ASCLEPIADACEAE)

Experiments (150 results)

Filters

Worktypes (31)

Pharmacology (39)

Compounds (47)

Organisms (45)